Skip to main content
HairCited

Spironolactone لـ الثعلبة الأندروجينية

A

بناءً على 25 دراسة (4 meta-analyses, 2 RCTs) بمشاركة 6,273 مشاركًا إجمالاً. 19/25 دراسة تُظهر تأثيرات إيجابية.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dspironolactone\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

الخلاصة

Spironolactone is well-supported by research as an anti-androgen medication that may help reduce hair loss in androgenetic alopecia, particularly in women, though it requires medical supervision.

  • 76% of studies show positive effects, backed by 4 meta-analyses
  • Works by blocking androgen hormones that contribute to hair miniaturization
  • Particularly studied in women with PCOS-related and female pattern hair loss
  • Requires prescription and medical monitoring due to hormonal effects

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None مقابل: None Outcome: None التأثير: None None

المجتمع المدروس: women with androgenetic alopecia (female pattern hair loss)

Review
Male and female pattern hair loss.
Dose: None مقابل: Placebo التأثير: None None
RCT n=48 24 weeks Double-blind
Efficacy and safety of oral spironolactone for female pattern hair loss in premenopausal women: a …
Dose: Spironolactone 100 mg once daily مقابل: Placebo التأثير: Terminal hair counts: 9.48 vs 5.32 hairs/cm2; hair diameter: 4.23 vs 2.96 μm; moderate-to-marked imp p=0.063 (terminal hair counts)
Randomized Controlled Trial n=125 4 weeks Double-blind
Effects of a cannabidiol/terpene formulation on sleep in individuals with insomnia: a double-blind, placebo-controlled, randomized, …
Dose: CBD 300 mg + 1 mg each of 8 terpenes مقابل: Placebo Outcome: Percentage of time in SWS + REM sleep التأثير: 1.3% increase [0.1-2.5%]; up to 48 min/night in su 0.03

المجتمع المدروس: Individuals with insomnia

Cohort Study n=203
An international multicenter, retrospective cohort study of 203 patients with pediatric androgenetic alopecia.
Dose: None مقابل: None Outcome: Clinical presentation and treatment outcomes in pediatric AGA التأثير: None None

المجتمع المدروس: Pediatric patients with androgenetic alopecia (multicenter)

Randomized Controlled Trial n=30
A Prospective and Comparative Study to Explore the Effects of Platelet-Rich Plasma in Hair Transplantation …
Dose: None مقابل: Drug therapy (minoxidil + finasteride/spironolactone) only Outcome: Follicle survival rate, growth rate, hair strength التأثير: None None

المجتمع المدروس: Patients with androgenetic alopecia

Key Statistics

45

الدراسات

6472

المشاركون

Positive

A

التقييم

Referenced Papers

Australian prescriber 2025 2 اقتباسات
Biomedicines 2024 17 اقتباسات
Journal of cosmetic … 2024 11 اقتباسات
JAAD international 2023 80 اقتباسات
Clinical, cosmetic and … 2023 58 اقتباسات
Journal of the … 2023 20 اقتباسات
Alternative therapies in … 2020 11 اقتباسات
Journal of the … 2019 95 اقتباسات
Journal of the … 2019 55 اقتباسات
International journal of … 2018 129 اقتباسات
BMJ case reports 2017 6 اقتباسات
The Cochrane database … 2016 18 اقتباسات
The Medical clinics … 2015 66 اقتباسات
Journal of the … 2015 50 اقتباسات
Current problems in … 2015 8 اقتباسات
International journal of … 2013
Seminars in cutaneous … 2009 4 اقتباسات
The Australasian journal … 2007 32 اقتباسات
Revue medicale de … 2004
Current pharmaceutical design 1999
Journal of the … 1999
Dermatologic clinics 1998 121 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

hairloss:
100-200 mg/day (prescription)

الحد الأعلى: 200 mg/day (hair loss indication)

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
None -- Neutral --
None -- Positive --
Spironolactone 100 mg once daily 24 weeks Positive 48
CBD 300 mg + 1 mg each of 8 terpenes 4 weeks Positive 125
None -- Positive 203
None -- Positive 30
various across included studies (2015-2024) -- Positive --
None -- Mixed --

أفضل وقت للتناول: Once or twice daily with food; prescription required

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Menstrual irregularities
  • Breast tenderness
  • Hyperkalemia (elevated potassium levels)
  • Dizziness and orthostatic hypotension
  • Frequent urination

التفاعلات المعروفة

  • ACE inhibitors and ARBs (increased hyperkalemia risk)
  • Potassium supplements and potassium-sparing diuretics (dangerous hyperkalemia)
  • NSAIDs (may reduce diuretic effectiveness and increase kidney risk)
  • Digoxin (spironolactone may increase digoxin levels)

الحد الأقصى المسموح به: 200 mg/day (hair loss indication)

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Spironolactone help with الثعلبة الأندروجينية?
Based on 45 studies with 6,472 participants, there is strong evidence from multiple clinical trials that Spironolactone may support الثعلبة الأندروجينية management. Our evidence grade is A (Strong Evidence).
How much Spironolactone should I take for الثعلبة الأندروجينية?
Studies have used various dosages. A commonly studied range is 100-200 mg/day (prescription). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Spironolactone?
Reported side effects may include Menstrual irregularities, Breast tenderness, Hyperkalemia (elevated potassium levels), Dizziness and orthostatic hypotension. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Spironolactone and الثعلبة الأندروجينية?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 45 peer-reviewed studies with 6,472 total participants. The overall direction of effect is positive.

Related Evidence

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.